Enhanced response of blood monocytes to in vitro lipopolysaccharide-challenge in patients with recurrent unstable angina

Circulation

Volumn 103, Issue 18, 2001, Pages 2236-2241

  Liuzzo, Giovanna ^a   Angiolillo, Dominick J ^a   Buffon, Antonino ^a   Rizzello, Vittoria ^a   Colizzi, Christian ^a   Ginnetti, Francesca ^a   Biasucci, Luigi M ^a   Maseri, Attilio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Angina; Inflammation; Interleukins; Leukocytes; Prognosis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEART INFARCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; RECURRENT DISEASE; STIMULUS RESPONSE; UNSTABLE ANGINA PECTORIS;

EID: 0035826792     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.18.2236     Document Type: Article

References (31)

1. Liuzzo G, Biasucci LM, Gallimore JR, et al. Prognostic value of C-reactive protein and Plasma Amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
2. Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 1999;99:855-860.
3. Thompson SG, Kienast J, Pyke SDM, et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
4. Haverkate F, Thompson SG, Pyke SDM, et al, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462-466.
5. Kuller LH, Tracy RP, Shaten J, et al, for the MRFIT Research Group. Relation of C-Reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 1996;144:537-547.
6. Ridker PM, Cushman M, Stamper MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
7. Koenig W, Sund M, Fröhlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts the risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999;99:237-243.
8. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.
9. Ridker PM, Kundsin RB, Stampfer MJ, et al. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation. 1999;99:1161-1164.
10. Hoffmeister A, Rothenbacher D, Wanner P, et al. Seropositivity to Chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: negative results of a casecontrol study. J Am Coll Cordiol. 2000;35:112-118.
11. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
12. Libby P, Ridker PM. Novel inflammatory markers of coronary risk: theory versus practice. Circulation. 1999;100:1148-1150.
13. Liuzzo G, Buffon A, Biasucci LM, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation. 1998;98:2370-2376.
14. Liuzzo G, Biasucci LM, Gallimore JR, et al. Enhanced inflammatory response in patients with pre-infarction unstable angina. J Am Coll Cordiol. 1999;34:1696-1703.
15. Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
16. DeForge LE, Kenney JS, Jones ML, et al. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. J Immunol. 1992;148:2133-2141.
17. Van Deventer SJH, Büller HR, Cate JW, et al. Endotoxemia: an early predictor of septicemia in febrile patients. Lancet. 1988;1:605-611.
18. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine. 1992;4: 361-368.
19. Pue CA, Mortensen RF, Marsh CB, et al. Acute phase levels of C-reactive protein enhance IL-1β and IL-1ra production by human blood monocytes but inhibit IL-1β and IL-1ra production by alveolar macrophages. J Immunol. 1996;156:1594-1600.
20. Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82: 513-520.
21. Santamaria P, Gehrz RC, Bryan MK, et al. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes: quantitative differences at the polymorphic level. J Immunol. 1989; 143:913-922.
22. Liao F, Andalibi A, de Beer FC, et al. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest. 1993;91: 2572-2579.
23. Sancéau J, Kaisho T, Hirano T, et al. Triggering of the human interleukin-6 gene by interferon-γ and tumor necrosis factor-α in monocytic cells involves cooperation between interferon regulatory factor-1, NFκB, and SP1 transcription factors. J Biol Chem. 1995;270: 27920-27931.
24. Kamdar SJ, Fuller JA, Nishikawa SI, et al. Priming of mouse macrophages with the macrophage colony-stimulating factor (CSF-1) induces a variety of pathways that regulate expression of the interleukin 6 and granulocyte-macrophage colony-stimulating factor genes. Exp Cell Res. 1997;235:108-116.
25. Chapoval AI, Kamdar SJ, Kremlev SG, et al. CSF-1 (M-CSF) differentially sensitizes mononuclear phagocyte subpopulations to endotoxin in vivo: a potential pathway that regulates the severity of gram-negative infections. J Leukoc Biol. 1998;63:245-252.
26. Liuzzo G, Kopecky SL, Frye RL, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999;100: 2135-2139.
27. Kol A, Sukhova GK, Lichtman AH, et al. Chlamydial heat shock protein 60, which was found in human atheroma, modulates macrophage TNF-alpha and matrix metalloproteinase expression. Circulation. 1998; 98:300-307.
28. Pasceri V, Cammarota G, Patti G, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation. 1998;97: 1675-1679.
29. Koening W, Rothenbacher D, Hoffmeister A, et al. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of systemic inflammatory response. Circulation. 1999;100:236-231.
30. Whincup P, Danesh J, Walker M, et al. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation. 2000;101:1 647-652.
31. Hubacek JA, Pit'ha J, Skodova Z, et al. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation. 1999;99:3218-3220.